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ABSTRACT
Background: Candida albicans is a memeber of the oral flora that can lead to
arious complications in immunosupresive patients after oral surgery processes.
nkaferd Blood Stopper® (ABS) is a medical plant extract that is safe to use in
patients with dental surgery bleedings in Turkey.
Objective: The study evaluated the antifungal activity of ABS medicinal plant
xtract against C albicans using the agar diffusion and broth microdilution methods.
Methods: The plant extract antifungal activity was assessed in vitro either by
pplying the ABS extract directly and by applying different concentrations of ABS
nto Candida culture. For these experiments, an agar diffusion method was used. To
determine the minimum inhibitory concentration (MIC), a broth microdilution
method was used.
Results: Different volumes of the active substance (10, 20, 30, and 40 L)
ere applied onto Candida (0.5 McFarland solution) cultivated plate; Candida growth
was inhibited in accordance with the volumes of ABS. However, when various
dilutions of ABS (1:2, 1:20, 1:40, and 1:80) were added as drops containing 20 L,
o antifungal effects were found. No MIC values were identified using broth mi-
rodilution. When different dilutions of ABS containing 100 L of 0.5 McFarland
solution of C albicans were cultured depending on the time (10, 20, 30, and 40
minutes), the effect of the duration was not significant.
Conclusion: The various tests were carried out to investigate antifungal
ffects of ABS on Candida, but none were found. (Curr Ther Res Clin Exp. 2011;72:
20-126) © 2011 Elsevier HS Journals, Inc. All rights reserved.
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Ankaferd Blood Stopper® (ABS) (Ankaferd Ilaç Kozmetik AS, Istanbul, Turkey) is a
edicinal plant extract that has been used in Turkish traditional medicine as a
emostatic agent.1 Ankaferd produces a unique hemostatic effect by promoting very
apid (1 sec) formation of a protein network, which acts as an anchor for vital
hysiologic erythrocyte aggregation and covers the classic cascade model of the
lotting system without acting independently on coagulation factors and platelets.1,2
ABS may be effective in both individuals with normal hemostatic parameters and in
patients with deficient primary hemostasis and/or secondary hemostasis.1 Excessive
bleeding, particularly in patients with hereditary or acquired hemorrhagic diathesis,
is challenging for dental practitioners.3 Antithrombotic, procoagulant, and antifi-
rinolytic medications are frequently used for the management of bleeding in
entistry.4 ABS as a medicinal product was approved in the management of external
hemorrhage and dental surgical bleeding in Turkey based on tolerability and efficacy
reports.4,5
ABS includes 5 plants: Thymus vulgaris, Glycyrrhiza glabra, Vitis vinifera, Alpinia
officinarum, and Urtica dioica in a weight ratio of 6, 8, 7, 7, and 5, respectively.1,5 ABS
can be used as a spray, solution, or tampon.2 Ankaferd has shown a high inhibitory
ctivity against both gram-negative and -positive bacteria.6 The antimicrobial activ-
ity of ABS has been reported in multidrug resistant bacteria such as methicillin-
resistant Staphylococcus aureus, Enterococcus spp, Enterobacter spp, Escherichia coli, Pseudomo-
nas aeruginosa, and Acinetobacter baumannii bacteria.7
C albicans is normally located in the oral cavity8 and the oral mucosa. Because it
is an opportunistic pathogen, it can cause candidiasis in immunosuppressed patients,
such as those with febrile neutropenia or hematologic malignancy and chronic
conditions like diabetes mellitus.9,10 Surgery can also cause Candida infection in this
roup of patients.
Because in vitro antifungal activity of ABS is unknown, the activity of ABS against
albicans was evaluated.
MATERIALS AND METHODS
Ankaferd Blood Stopper
The standardized vials of ABS (1 vial of 100 mL) used in these experiments were
onated by Ankaferd Drug Inc, Istanbul, Turkey.
C albicans Isolates
A total of 4 isolates were tested, with the result of 1 standard C albicans (ATCC
0028) and 3 clinical isolates. The clinical isolates were isolated from mouth swabs.
he antifungal activity assay was performed by an agar culture method. C albicans
tocks were stored at –70°C in their respective broths, supplemented with 3%
lycerol.
Preparation of Standard Candida Inoculums
Stock inoculum suspensions of standard Candida were prepared in sterile saline(8.5 g/L) sodium chloride from 24- to 48-hour cultures on Sabouraud dextrose agar
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Current Therapeutic Research(SDA) plates at 37°C, and the Candida strain concentration was adjusted to 0.5
cFarland standard solution.11
Effect of Ankaferd on the Colony Formatıon of C Albicans
The antifungal activity of the ABS against the Candida strains selected was
etermined using an agar diffusion method. The standard solution of each tested
train was swabbed over SDA plates. After 10 minutes, various volumes of ABS (10,
0, 30, and 40 L) were placed on 4 different points of the agar surface. All plates
ere incubated at 37°C for 24 to 48 hours, and the inhibition zone was evaluated.
Standard Microdilution Method
The antifungal susceptibility of Candida strains was determined using a broth
ilution method as described in Clinical Laboratory Standards Institute standard
27-A2.11 Using this method, the antifungal effect of ABS was investigated. The
concentration range of the ABS used was between 0.03 and 350 g/mL.
Diluted Active Substance Effect Over Time
Only the standard C albicans strain was used to investigate the effect of ABS. The
inoculum strain was adjusted to the turbidity of the 0.5 McFarland standard solution.
To observe the effect of ABS on the known colony number of C albicans, 10–3
dilutions of 0.5 McFarland solution were used in these experiments. The dilutions of
ABS (1/2, 1/20, 1/40, and 1/80), each containing 100 L of the 10–3dilution of the
.5 McFarland solution (inoculum), were prepared. The ABS dilutions and inoculums
ere incubated at 37°C in a water bath for 10, 20, and 40 minutes. At different time
oints, aliquots of 20 L were dropped onto SDA plates. A tube including only
inoculum and no ABS was used as the control, and 20 L of the tube content was also
laced onto SDA plates. After the plates dried, they were incubated at 37°C for 24
ours.
Additionally, 0.5 McFarland solution and its 3 dilutions (10–1, 10–2, 10–3) were
pread on SDA plates. After 10 minutes, 20 L of extract was dropped onto the 4
points. These were incubated for 24 hours at 37°C. Laboratory personnel evaluating
the growth of Candida were blind to the concentrations applied.
RESULTS
Effect of Ankaferd Blood Stopper on C albicans
Because we investigated only the effect of ABS medicinal plant extract against
tandard C albicans strain, positive and negative controls were not used. The anti-
ungal activity of ABS was tested in a total of 4 Candida strains. The surface area of
he SDA 0.5 McFarland standard solution applied to the 4 different points (10, 20,
0, and 40 L) of ABS was measured so that the inhibition zone diameters were
obtained. It was observed that the diameters of zone of inhibition increased with
increasing volume of ABS, as shown in Figure 1.
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The test was repeated 3 times, but the MIC values could not be determined. The
ubstances in liquid medium were coagulated by ABS.
Diluted Active Substance Effect Over Time
There was no evidence of an effect for duration of (10, 20, and 40 minutes)
xposure of ABS on Candida growth (Figure 2).
When active substance concentrations (1:2, 12:20, 1:40, and 1:80) were dropped
nto a plate containing inoculums, no inhibitory effect was observed (Figure 3).
30 mL
10 mL
40 mL
20 mL
Figure 1. The effect of different volumes of Ankaferd Blood Stopper on Candida albicans
colonies.
Figure 2. The numbers of Candida colonies counted on agar plates inoculated with 10–3
dilution of 0.5 McFarland solution of Candida albicans containing Ankaferd
Blood Stopper (ABS) and its dilutions after 10-, 20- and 40-minute incubations.
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The ABS medical plant extract is used in medicine as a hemostatic agent, which has
been shown to promote the formation of an encapsulated protein network.1
ABS containing T vulgaris, G glabra, V vinifera, A officinarum, and U dioica plant
xtracts was investigated separately for antimicrobial and antifungal effects. T vulgaris
andida was used in studies investigating the antifungal effect.12–14 Fatima et al15
found G glabra active against both yeast and filamentous fungi. Furthermore, Pellati
et al16 demonstrated the in vitro activity of the compound 18- glycyrrhetinic acid
gainst C albicans strains derived from the root of Glycyrrhiza species. Motsei et al17
reported that G glabra had an antifungal effect on C albicans in clinical specimens, and
hat it could be used in oral mouthwashes for the treatment of oral candidiasis.
Hemorrhagic diathesis during dental surgery can prolong postoperative bleeding,
mpair wound healing, and increase the risk of infection.3 Bacteria and fungi prolif-
rate in the oral cavity and contamination of the surgical field by this flora can occur
ery easily. In recent studies, it was shown that ABS inhibited the in vitro growth of
ram-negative and -positive bacteria.6,18 In this study, the activity of ABS against C
lbicans was evaluated.
In the first phase of the study, the active substance volume was not diluted by the
pecific density. When Candida strains were cultivated onto a plate and different
oncentrations of ABS (40, 30, 20, and 10 L) were dropped onto it, it was found that
the greater the concentration of ABS, the greater the inhibition of Candida growth.
These results suggested that ABS inhibited the growth of Candida. This effect
suggested that there were antifungal properties of T vulgaris and G glabra. However,
in other phases of the study with the active substance concentrations (1:2, 1:20, 1:40,
and 1:80) and 0.5 McFarland solution Candida strains added as drops of plaque at 20
L, the anti-fungal effects were not determined. It is possible that, because a
Figure 3. Inhibitory effect of active substance concentrations.combination of T vulgaris and G glabra was used, antifungal effects could not be
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S. Ciftci et al.obtained. In addition, the different dilutions of ABS against Candida over time (10,
0, and 40 minutes) were evaluated and compared with the control tubes, but the
ffect of duration was negligible. Therefore, the ABS effects, depending on the
uration of the application period, were not considered when it was applied on a
ound infected with fungus.
The antifungal activity of ABS is not precisely known. Akkoc et al19 assessed the
ntifungal effect of ABS using an agar well diffusion test. ABS was found to have a
igh antifungal effect against Zygosaccharomyces bailii, C albicans, Aspergillus flavus, and
spergillus parasiticus. However, in this study, there was no observed effect of ABS on
andida that was considered to be an antifungal effect. However, when ABS was
irectly applied onto Candida, it resulted in changes in the growth conditions. The
ixture of plant extracts in ABS might have antifungal effects separately; however,
hen used together, the antifungal effect could not be demonstrated. The limitation
f this study was that ABS was only tested against Candida, which is 1 of the most
ommon oral flora. However, to support this conclusion convincingly, additional
tudies using a large number of clinical specimens need to be performed.
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